Pangaea invests in NewLeaf Symbiotics' $30 mln Series C
St. Louis, Missouri-based agricultural biologicals company NewLeaf Symbiotics Inc has secured US$30 million in the second close of its Series C financing. S2G Ventures joined first close lead investors Monsanto Growth Ventures and Otter Capital, as well as other participating investors, among them Pangaea Ventures, a Canadian venture capital firm. NewLeaf said it plans to use the funds raised to commercialize seed treatment and in-furrow products for soybeans, corn, wheat, peanuts, and other crops. Vancouver-based Pangaea, which has backed NewLeaf since 2013, is currently raising its fourth advanced-materials fund.
13 September 2017•3 mins read
